Certara Products - Phoenix Archives

Case Study

Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection

PK/PD Modeling for CNS drug development using Phoenix NLME and machine learning for better CNS…

Certara2026 年 3 月 26 日

Publication

Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis

This study evaluated the pharmacokinetics (PK) and pharmacokinetic–pharmacodynamic (PK–PD) relationship of clazakizumab, an anti–interleukin-6 (IL-6)…

Danielle Pillsbury2026 年 3 月 24 日

Guide

From Numbers to Narrative: Mastering the Art of PK Presentation

Master PK data reporting with a structured guide to presenting pharmacokinetic results clearly and turning…

Certara2026 年 3 月 20 日

Webinar

Pharmacometrics Under Pressure

Certara2026 年 3 月 20 日

博客

What are Common Bioequivalence Study Mistakes?

Learn about the most common bioequivalence study mistakes drug developers make and the differences between…

Certara2026 年 3 月 20 日

网络研讨会

Phoenix 8.8 有哪些新功能？

Danielle Pillsbury2026 年 3 月 9 日

Webinar

Modeling Platinum-Induced Nephrotoxicity: A PK/TD Analysis of Calbindin and B2-Microglobulin Urinary Biomarkers

Certara2026 年 3 月 9 日

Guide

Navigate GxP Compliance in the Cloud with Confidence

Master SaaS GxP compliance with risk-based computer system validation (CSV) aligned to GAMP 5, FDA,…

Certara2026 年 3 月 6 日

Blog Knowledge Base

Understanding and Calculating Steady State Pharmacokinetics

Steady state pharmacokinetics can seem abstract and confusing. Read this blog to gain a better…

Certara2026 年 3 月 5 日

Live Events

Phoenix Roadshow 2026 – 英国剑桥

Certara2026 年 3 月 2 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Certara Products – Phoenix

Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection

Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis

From Numbers to Narrative: Mastering the Art of PK Presentation

Pharmacometrics Under Pressure

What are Common Bioequivalence Study Mistakes?

Phoenix 8.8 有哪些新功能？

Modeling Platinum-Induced Nephrotoxicity: A PK/TD Analysis of Calbindin and B2-Microglobulin Urinary Biomarkers

Navigate GxP Compliance in the Cloud with Confidence

Understanding and Calculating Steady State Pharmacokinetics

Phoenix Roadshow 2026 – 英国剑桥

订阅时事通讯

快捷链接

解决方案

联系我们